The Swedish tumor microenvironment meeting: Cancer scaffolds posters

Iscaffpharma ‘s cost-effective  platform for aggressive cancer is being presented at “The Swedish tumor microenvironment meeting” in Umeå 9th till 11th of April 2019. The poster presentations covers the use in cancer drug discovery of  scaffolds or PDS (Patient derived scaffold) that will effectively change the way new targets and drugs for cancer treatment can be evaluated.

The presented posters are:

•  Screening of FDA-approved drugs for the targeting of breast cancer stem cells using the novel cancer patient derived scaffold; presented by Elena Garre Sahlgrenska Cancer Center. 
• Scaffolds derived from breast cancer as a model to study drug response; presented by Maria Carmen Leiva Sahlgrenska Cancer Center.

The data shows that Iscaffpharma’s platform is able to improve success rate in clinical development of treatments for aggressive cancer in a cost-effective way.

Iscaffpharma wishes the presenters good luck in Umeå!